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Introduction {#cam4778-sec-0001}
============

Thyroid cancer is the most common endocrine malignancy. Approximately 62,980 cases of thyroid cancer were newly diagnosed in the United States in 2014, and the number continues to increase annually [1](#cam4778-bib-0001){ref-type="ref"}. Much attention is focused on differentiated thyroid cancer (DTC), a disease that accounts for more than 90% of thyroid cancers but tends to have an indolent clinical course with low morbidity and mortality [2](#cam4778-bib-0002){ref-type="ref"}, [3](#cam4778-bib-0003){ref-type="ref"}. Survival analysis in the study by Davies and Welch indicates that mortality rates for thyroid cancer have remained steady at 0.5 deaths per 100,000[4](#cam4778-bib-0004){ref-type="ref"}, [5](#cam4778-bib-0005){ref-type="ref"}. More specific studies of the SEER database utilizing relative survival show different thyroid cancer survival rates based on sex, ethnicity, tumor histology, and stage [6](#cam4778-bib-0006){ref-type="ref"}. The 5‐year relative survival rates have increased among women, from 92.7% in 1974 to 97.4% in 2001[6](#cam4778-bib-0006){ref-type="ref"}. However, the annual percentage change (APC) in thyroid cancer mortality rates in men increased by 2.4%, which is among the largest increases in cancer mortality rates of men in the United States [7](#cam4778-bib-0007){ref-type="ref"}. Mortality rates are also affected by race, tumor features, and treatments. [8](#cam4778-bib-0008){ref-type="ref"}, [9](#cam4778-bib-0009){ref-type="ref"}, [10](#cam4778-bib-0010){ref-type="ref"}, [11](#cam4778-bib-0011){ref-type="ref"}. Generally, the patients with DTC present a favorable prognosis except for the delayed diagnosis and advanced stage at the time of initial therapy.

It is well known that social support and environmental factors may influence overall mental state of well‐being, so as to exerting a significant effect on the outcome, especially for cancer patients. It has been shown that married persons have better mood and receive more social support, including practical support and financial resources, so that they can focus on treatment and generally show a better recovery from a single malignancy. In all of the top 10 causes of cancer death in the United States, the survival benefit associated with marriage was even larger than the published survival benefit from chemotherapy in prostate, breast, colorectal, and esophageal cancers [12](#cam4778-bib-0012){ref-type="ref"}, [13](#cam4778-bib-0013){ref-type="ref"}. However, little is known with respect to the prognostic significance of marital status in DTC patients. A better understanding of the impact of marital status on thyroid cancer patients would give more support on the importance of social mechanisms in management of this endocrine malignancy and help establish a more holistic approach that may improve patient outcomes. In this study, we extracted data from the Surveillance, Epidemiology and End Results (SEER) cancer‐registry program of individuals diagnosed as DTC between 2002 and 2012 to explore the relationship between a certain marital status and the survival of patients in detail.

Methods {#cam4778-sec-0002}
=======

Patient selection from the SEER database {#cam4778-sec-0003}
----------------------------------------

We extracted data from the SEER cancer registry to conduct this study. SEER, a population‐based registry sponsored by the National Cancer Institute, collects information on cancer incidence and survival from 17 population‐based cancer registries, including approximately 28% of the US population [14](#cam4778-bib-0014){ref-type="ref"}. SEER data contains no identifiers and is publicly available for studies on cancer‐based epidemiology and health policy. The National Cancer Institute\'s SEER\*Stat software (Surveillance Research Program, National Cancer Institute SEER\*Stat software, [www.seer.cancer.gov/seerstat](http://www.seer.cancer.gov/seerstat)) (Version 8.1.2) was used to identify patients who were diagnosed from 2002 to 2012, with single primary DTC. Patients with surgical and postoperative radioactive therapy for PTC were included. Histology types were limited to papillary carcinoma and its variants (8250, 8260, 8330, 8331, 8332, 8335, 8340, 8341, 8343, 8344). The patients were excluded if with: insufficient or unknown clinicopathologic‐profile, short follow‐up period (\<6 months), primary tumor rather than the above mentioned histologies, undetermined histology or other types of thyroid cancer (medullary and anaplastic carcinoma). The patients with papillary squamous cell carcinoma and oxyphilic variant were excluded due to the rarity that affected the efficiency of statistic analysis.

Clinicopathological variable assessment {#cam4778-sec-0004}
---------------------------------------

The variable of "marital status" referred to "the status at diagnosis" when not otherwise specified. Marital status was coded as married, divorced, widowed, and single (never married). Age, sex, race, histological subtype, TNM stage, survival time, and cause‐specific survival (CSS) were extracted from the SEER database. Race was categorized into African American, non‐Hispanic white, and others (American Indian/AK Native, Asian/Pacific Islander) as provided by the SEER database.

We followed the guidance of the 2010 TNM classification of American Joint Committee on Cancer/International Union Against Cancer [15](#cam4778-bib-0015){ref-type="ref"}, [16](#cam4778-bib-0016){ref-type="ref"}, [17](#cam4778-bib-0017){ref-type="ref"}. The endpoint of present study was CSS which was calculated from the date of diagnosis to the date of cancer‐specific death and was shown as "SEER cause‐specific survival" in SEER database.

Statistical analysis {#cam4778-sec-0005}
--------------------

Chi‐squared (*χ* ^2^) test was used to compare patients\' baseline characteristics. Survival rate was generated using Kaplan--Meier curve, and the differences were compared with the log‐rank test. Multivariate Cox regression models were applied to determine whether there was an association between marital status and CSS in patients receipt of definitive treatment, adjusted for patient demographics (as listed above) and tumor characteristics (tumor histology classification)[18](#cam4778-bib-0018){ref-type="ref"}.

Cox proportional hazards regression model was then built to evaluate the impact of marital status on cancer mortality from DTC among patients according to sex, age, and TNM stage after being adjusted for the previously listed variables as well as receipt of definitive therapy. Finally, the cumulative incidence of cancer‐specific mortality stratified by marital status was generated from Kaplan--Meier curve models described above and displayed graphically.

The hazard ratio (HR) for relationships between each variable and mortality was calculated using binary Cox regression model. All confidence intervals (CIs) were stated at the 95% confidence level. All *P* values were two‐sided. *P *\<* *0.05 was considered statistically significant. Statistical analysis was performed using SPSS software, version 13.0 (SPSS Inc., Chicago, IL).

Results {#cam4778-sec-0006}
=======

Patient characteristics {#cam4778-sec-0007}
-----------------------

A total of 61,077 eligible patients were identified during the 10‐year study period, including 13,388 male and 47,689 female patients. Among these patients, 40,527 (66.4%) were married, 2,768 (4.5%) were widowed, and 12,889 (21.1%) had never married. The 4,893 (8.0%) individuals who were divorced or separated were grouped together in the divorced group in our study. The widowed group had the highest proportion of women, most prevalent of elderly patients (≥45 years), most common of follicular subtype, most advanced stage III/IV tumor, and most distant metastasis, all of which were statistically significant (*P *\<* *0.001). In addition, the widowed group was older than any other marital status subgroup. The rates of total thyroidectomy (TT) and radioisotope therapy performed slightly varied between the married and widowed groups, but both were higher than those in the never married and divorced groups. Patient demographics and clinicopathological features are summarized in Table [1](#cam4778-tbl-0001){ref-type="table-wrap"}.

###### 

Clinicopathologic characteristics of DTC patients according to marital status in SEER database

  Characteristic                                All patients no. (%)   Marital status                                              
  --------------------------------------------- ---------------------- ---------------- ------------- -------------- ------------- ---------------------------------------------
  No. of patients                               61077 (100.0)          40527 (66.4)     2768 (4.5)    12889 (21.1)   4893 (8.0)    
  Sex                                                                                                                              
  Male                                          13388 (21.9)           9798 (24.1)      256 (9.2)     2547 (19.8)    787 (16.1)    0.001
  Female                                        47689 (78.1)           30729 (75.8)     2512 (90.8)   10342 (80.2)   4106 (83.9)   
  Age (mean ± SD)                               47.7 ± 14.8            48.9 ± 12.9      68.3 ± 11.9   38.0 ± 15.2    51.5 ± 12.1   
  \<45                                          25975 (42.5)           15937 (39.3)     108 (3.9)     8523 (66.1)    1407 (28.8)   0.001[b](#cam4778-note-0006){ref-type="fn"}
  Mean ± SD                                     33.8 ± 7.6             36.1 ± 5.7       38.0 ± 5.4    29.0 ± 8.6     37.0 ± 5.9    
  ≥45                                           35102 (57.5)           24590 (60.7)     2660 (96.1)   4366 (33.9)    3486 (71.2)   
  Mean ± SD                                     57.9 ± 9.6             57.1 ± 9.0       69.6 ± 10.4   55.5 ± 8.5     57.4 ± 8.6    
  Race                                                                                                                             
  Black                                         3869 (6.3)             1763 (4.4)       238 (8.6)     1383 (10.7)    485 (9.9)     0.001
  White                                         56566 (92.6)           38351 (94.6)     2515 (90.9)   11329 (87.9)   4371 (89.3)   
  Other[a](#cam4778-note-0005){ref-type="fn"}   642 (1.0)              413 (1.0)        15 (0.5)      177 (1.4)      37 (0.8)      
  Histology type                                                                                                                   
  Papillary                                     57427 (94.0)           38273 (94.4)     2535 (91.6)   12042 (93.4)   4577 (93.5)   0.001
  Follicular                                    3650 (6.0)             2254 (5.6)       233 (8.4)     847 (6.6)      316 (6.5)     
  T stage                                                                                                                          
  T1/T2                                         47104 (77.1)           31658 (78.1)     1969 (71.1)   9649 (74.9)    3828 (78.2)   0.001
  T3/T4                                         13973 (22.9)           8869 (21.9)      799 (28.9)    3240 (25.1)    1065 (21.8)   
  N stage                                                                                                                          
  N0                                            46913 (76.8)           31637 (78.1)     2274 (82.2)   9021 (70.0)    3981 (81.4)   0.001
  N1a                                           7098 (11.6)            4536 (11.2)      223 (8.1)     1905 (14.8)    434 (8.9)     
  N1b                                           7066 (11.6)            4354 (10.7)      271 (9.8)     1963 (15.2)    478 (9.8)     
  Distant Metastasis                            1602 (2.6)             937 (2.3)        122 (4.4)     428 (3.3)      115 (2.4)     0.001
  TNM Stage                                                                                                                        
  I                                             44537 (72.9)           29209 (72.1)     1469 (53.1)   10540 (81.8)   3319 (67.8)   0.001
  II                                            5088 (8.3)             3380 (8.3)       337 (12.2)    880 (6.8)      491 (10.0)    
  III                                           6991 (11.4)            4871 (12.0)      543 (19.6)    915 (7.1)      662 (13.5)    
  IV                                            4461 (7.3)             3.67 (7.6)       419 (15.1)    554 (4.3)      421 (8.6)     
  Surgery procedures                                                                                                               
  Lobe.±Isth.                                   8769 (14.4)            5840 (14.4)      504 (18.2)    1698 (13.2)    727 (14.9)    \>0.05
  Lobe.±Partial Contra‐lobe.                    457 (0.7)              305 (0.8)        29 (1.9)      79 (0.6)       44 (0.9)      
  TT or near TT                                 51851 (84.9)           34382 (84.8)     2235 (80.7)   11112 (86.2)   4122 (82.4)   
  Adjuvant therapy                                                                                                                 
  None                                          28158 (46.1)           18651 (46.0)     1468 (53.0)   5717 (44.4)    2322 (47.5)   \>0.05
  Radioisotopes                                 30512 (50.0)           20322 (50.1)     1167 (42.2)   6656 (51.6)    2367 (48.4)   
  Beam radiation                                2407 (3.9)             1554 (3.9)       133 (2.8)     516 (2.0)      204 (2.1)     

DTC, differentiated thyroid cancer; lobe., lobectomy; isth., isthmectomy; TT, total thyroidectomy; SD, standard deviation. Data are presented as *n* (%).

Including American Indian/AK Native, Asian/Pacific Islander.

*P*‐value refers to comparison for the differences in proportions among subgroups.
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Cancer‐specific survival post initial treatment by marital status on CSS in the SEER database {#cam4778-sec-0008}
---------------------------------------------------------------------------------------------

Married patients with DTC had a better CSS than those unmarried (*P *=* *0.001). Specifically, the overall 10‐year CSS was 97.3% in the married group, 93.9% in the widowed group, 99.6% in the never married group, and 97.3% in the divorced group, which were all significantly different according to the univariate log‐rank test (*P *=* *0.001) (Fig. [1](#cam4778-fig-0001){ref-type="fig"}). For clinicopathological variables, sex, age, histological subtype, T/N/M stage, adjuvant therapy, and marital status were identified as independent factors for predicting CSS on univariate analysis (Table [2](#cam4778-tbl-0002){ref-type="table-wrap"}). When multivariate analysis with Cox regression was performed, the variables which were validated as independent prognostic factors included: sex (female, HR 0.67, 95% CI: 0.55--0.82), age (≥45 years, HR 13.53, 95% CI: 8.65--21.18), tumor stage (T3/4, HR 5.00, 95% CI: 3.97--6.28), node stage (N1a, HR 1.71, 95% CI: 1.29--2.28; N1b, HR 1.77, 95% CI: 1.39--2.26), metastasis (distant, HR 6.65, 95% CI: 5.29--8.35), adjuvant therapy (beam radiation, HR 5.50, 95% CI: 4.15--7.30), and marital status (widowed, HR 2.95, 95% CI: 2.28--3.81; divorced, HR 1.78, 95% CI: 1.34--2.37).

![Survival curves in differentiated thyroid cancer patients according to marital status. (*χ*2 = 251.470, *P *=* *0.001).](CAM4-5-2145-g001){#cam4778-fig-0001}

###### 

Univariate and multivariate survival analysis for the influence of marital status on CSS in DTC from SEER database

  Variable                     Univariate analysis    Multivariate analysis                         
  ---------------------------- ---------------------- ----------------------- --------------------- -------
  Sex (Female vs. Male)        0.37 (0.31--0.44)      0.001                   0.67 (0.55--0.82)     0.001
  Age (≥45 vs. \<45)           16.83 (10.87--26.07)   0.001                   13.53 (8.65--21.18)   0.001
  Race (White vs. Black)       1.39 (0.90--2.12)      0.135                   1.32 (0.86--2.05)     0.206
  Follicular vs. Papillary     2.21 (1.69--2.88)      0.001                   1.30 (0.97--1.74)     0.073
  T3/4 vs. T1/2                10.34 (8.40--12.72)    0.001                   5.00 (3.97--6.28)     0.001
  N stage                                                                                           
  N0                           Reference                                      Reference             
  N1a                          2.41 (1.84--3.15)      0.001                   1.71 (1.29--2.28)     0.001
  N1b                          5.82 (4.79--4.07)      0.001                   1.77 (1.39--2.26)     0.001
  Distant Metastasis           23.65 (19.64--28.49)   0.001                   6.65 (5.29--8.35)     0.001
  Surgery Procedures                                                                                
  Lobe.±Isth.                  Reference                                      Reference             
  Lobe.±Partial Contra‐lobe.   0.61 (0.15--2.48)      0.484                   0.48 (0.12--1.96)     0.305
  TT or near TT                1.27 (0.96--1.67)      0.092                   0.76 (0.57--1.01)     0.056
  Adjuvant therapy                                                                                  
  None                         Reference                                      Reference             
  Radioisotopes                1.94 (1.55--2.42)      0.001                   1.19 (0.94--1.51)     0.15
  Beam radiation               21.72 (16.73--28.20)   0.001                   5.50 (4.15--7.30)     0.001
  Marital Status                                                                                    
  Married                      Reference                                      Reference             
  Widowed                      4.98 (3.91--6.34)      0.001                   2.95 (2.28--3.81)     0.001
  Never married                0.69 (0.52--0.92)      0.011                   1.10 (0.83--1.47)     0.500
  Divorced                     1.83 (1.38--2.43)      0.001                   1.78 (1.34--2.37)     0.001

DTC, differentiated thyroid cancer; CSS, cancer‐specific death; lobe., lobectomy; isth., isthmectomy; TT, total thyroidectomy.
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Subgroup analysis for evaluating the effect of marital status according to sex, age, and TNM stage {#cam4778-sec-0009}
--------------------------------------------------------------------------------------------------

Results from the Cox proportional hazards regression models identified and verified a series of risk predictors for mortality in DTC, including sex, age, and advanced stage, which were consistent with previous studies [19](#cam4778-bib-0019){ref-type="ref"}, [20](#cam4778-bib-0020){ref-type="ref"}. Then, we conducted subgroup analysis for the effects of marital status on survival in patients stratified by them. Using the proportional hazards regression models, we found that: 1) being widowed was associated with poorer survival than being married at each sex and age subgroup and all stages of cancer after being adjusted for the aforementioned variables and definitive treatments (*P *=* *0.001); 2) being divorced increased the risk for mortality compared with being married in males (HR 1.81, 95% CI: 1.14--2.87), female (HR 1.73, 95% CI: 1.21--2.49), elderly patients (≥45, HR 1.74, 95% CI: 1.30--2.32) and stage IV cancers (HR 1.90, 95% CI: 1.35--2.65); 3) the difference between the never married and married group was not apparent at each subgroup. (Table [3](#cam4778-tbl-0003){ref-type="table-wrap"}, Fig. [2](#cam4778-fig-0002){ref-type="fig"}, [3](#cam4778-fig-0003){ref-type="fig"}, [4](#cam4778-fig-0004){ref-type="fig"}).

###### 

Univariate and multivariate analysis of marital status on CSS in DTC according to sex, age and cancer stage

  Variable        Univariate analysis    Multivariate analysis                          
  --------------- ---------------------- ----------------------- ---------------------- -------
  Sex                                                                                   
  Male                                                                                  
  Married         Reference                                      Reference              
  Widowed         4.61 (2.71--7.85)      0.001                   2.72 (1.59--4.65)      0.001
  Never married   0.75 (0.50--1.13)      0.173                   1.24 (0.81--1.88)      0.327
  Divorced        1.94 (1.22--3.06)      0.005                   1.81 (1.14--2.87)      0.011
  Female                                                                                
  Married         Reference                                      Reference              
  Widowed         7.15 (5.36--9.54)      0.001                   2.02 (2.24--4.06)      0.001
  Never married   0.74 (0.50--1.09)      0.126                   1.13 (0.76--1.67)      0.553
  Divorced        2.22 (1.54--3.18)      0.001                   1.73 (1.21--2.49)      0.003
  Age                                                                                   
  \<45                                                                                  
  Married         Reference                                      Reference              
  Windowed        15.96 (2.02--126.00)   0.001                   28.12 (3.48--227.25)   0.002
  Never married   1.90 (0.75--4.78)      0.174                   1.46 (0.57--3.74)      0.436
  Divorced        2.50 (0.54--11.57)     0.241                   2.92 (0.62--13.72)     0.176
  ≥45                                                                                   
  Married         Reference                                      Reference              
  Widowed         3.18 (2.49--4.05)      0.001                   2.97 (2.30--3.83)      0.001
  Never married   1.11 (0.82--1.50)      0.503                   1.11 (0.82--1.50)      0.518
  Divorced        1.57 (1.18--2.09)      0.002                   1.74 (1.30--2.32)      0.001
  TNM stage                                                                             
  Stage I                                                                               
  Married         Reference                                      Reference              
  Widowed         10.82 (5.38--21.74)    0.001                   8.44 (4.05--17.59)     0.001
  Never married   1.22 (0.5802.56)       0.602                   1.74 (0.81--3.78)      0.159
  Divorced        1.95 (0.74--5.11)      0.178                   1.87 (0.71--4.95)      0.208
  Stage II                                                                              
  Married         Reference                                      Reference              
  Widowed         2.46 (0.93--6.52)      0.071                   3.64 (1.30--10.20)     0.014
  Never married   1.21 (0.49--3.00)      0.670                   1.08 (0.41--2.84)      0.879
  Divorced        1.32 (0.45--3.85)      0.610                   1.64 (0.56--4.82)      0.366
  Stage III                                                                             
  Married         Reference                                      Reference              
  Widowed         2.01 (0.98--4.12)      0.058                   2.27 (1.08--4.78)      0.031
  Never married   0.88 (0.39--1.95)      0.749                   0.92 (0.41--2.05)      0.829
  Divorced        1.20 (0.54--2.66)      0.665                   1.23 (0.55--2.76)      0.613
  Stage IV                                                                              
  Married         Reference                                      Reference              
  Widowed         2.73 (2.05--3.65)      0.001                   2.63 (1.94--3.57)      0.001
  Never married   1.13 (0.79--1.62)      0.501                   1.07 (0.75--1.54)      0.710
  Divorced        1.802 (1.29--2.51)     0.001                   1.90 (1.35--2.65)      0.001

DTC, differentiated thyroid cancer; CSS, cancer‐specific death. *P* values refer to comparisons between two groups and were adjusted for age, race, histologic type, surgery procedures, as covariates. NI: not included in the multivariate survival analysis.
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![Survival curves in differentiated thyroid cancer patients according to marital status in males and females. (A) Male: *χ*2 = 49.840, *P *=* *0.001; (B) Female: *χ*2 = 282.741, *P *=* *0.001.](CAM4-5-2145-g002){#cam4778-fig-0002}

![Survival curves in differentiated thyroid cancer patients according to marital status in youths and the elderly. (A) \<45 years: *χ*2 = 11.717, *P *=* *0.008; (B) ≥45 years: *χ*2 = 98.826, *P *=* *0.001.](CAM4-5-2145-g003){#cam4778-fig-0003}

![Survival curves in differentiated thyroid cancer patients according to marital status in different stages. (A) Stage I: *χ*2 = 71.886, *P *=* *0.001; (B) Stage II:*χ*2 = 3.496 *P *=* *0.321; (C) Stage III:*χ*2 = 4.186, *P *=* *0.242; (D) Stage IV:*χ*2 = 55.244, *P *=* *0.001.](CAM4-5-2145-g004){#cam4778-fig-0004}

Discussion {#cam4778-sec-0010}
==========

Dating back to the 19th century, the literatures showed that married persons had decreased death rates from a variety of diseases [21](#cam4778-bib-0021){ref-type="ref"}. Cancer is a major public health problem on a global scale. One in four deaths in the United States is due to cancer [7](#cam4778-bib-0007){ref-type="ref"}. In the United States, it is also reported that 51% of Americans are married [13](#cam4778-bib-0013){ref-type="ref"}. Therefore, the presence of a consistent association between marital status and outcome across multiple cancers would support the notion that unmarried patients with any malignancy represent a high‐risk population that might benefit from targeted, support‐based interventions [13](#cam4778-bib-0013){ref-type="ref"}. However, current studies assessing the impact of marital status on CSS among patients with cancer have presented conflicting results, and few of them have investigated the effects of marital status on patient survival or focused on the heterogeneity of unmarried patients in DTC. This study was designed to determine how marital status at diagnosis affected cancer mortality in the entire cohort and all categories were stratified by traditional prognostic factors, such as sex, age, and AJCC cancer stage.

In the analyses conducted thus far, it was indicated that marital status was an independent prognostic factor in DTC patients; additionally, the increased relative risks of DTC death was significant among widowed patients compared with married patients at each sex, age subgroup and all stages of cancer. The results were similar with previous researches investigating the associations between marital status and survival in breast, lung, colorectal, esophageal, and gastric cancers. [22](#cam4778-bib-0022){ref-type="ref"}, [23](#cam4778-bib-0023){ref-type="ref"}, [24](#cam4778-bib-0024){ref-type="ref"}, [25](#cam4778-bib-0025){ref-type="ref"}. While the mechanism underlying the improved survival associated with marriage in patients is not entirely clear, with the analyses from this study, the possible reasons for the unfavorable prognosis of unmarried patients, especially for widowed or divorced ones, are proposed as follows. First, widowed or divorced patients tend to be diagnosed as DTC at an elderly age. Age is considered to be the most important prognostic factor as demonstrated by the majority of current risk stratification systems. To the best of our knowledge, TNM classification is the only staging system that adopts 45‐year as the cut‐off value for age to stratify the patients in high‐ and low‐risk groups for cancer‐specific mortality [16](#cam4778-bib-0016){ref-type="ref"}, [17](#cam4778-bib-0017){ref-type="ref"}. The fact that the widowed group has the highest proportion of elderly patients (≥45 years) and greatest overall mean age becomes one hypothesis to explain the influence of marital status on prognosis in DTC. Second, widowed or divorced patients, tend to be diagnosed at a late stage of disease. The high incidence of advanced stage III/IV tumor and distant metastasis in the widowed group suggests a spread of primary tumor that conferred to a poor prognosis; however, the rates of surgical resection (TT performed) and radioisotopes therapy are both the lowest in the widowed group, which is a reflection for undertreatment of definitive or potentially curative therapies in these patients.

It is noteworthy that our results were consistent with previous studies in which married patients with head and neck cancer had the greatest relative reduction in cancer‐related death compared with unmarried patients [12](#cam4778-bib-0012){ref-type="ref"}, [13](#cam4778-bib-0013){ref-type="ref"}. Interestingly, recent data also reported that the impact of marital status on mortality varied with sex and age in some cancers [23](#cam4778-bib-0023){ref-type="ref"}, [26](#cam4778-bib-0026){ref-type="ref"}. As sex and age are known to possibly interact with marital status in a general population, we further tested associations in subgroups stratified by them. However, our data revealed that unmarried patients, especially for widowed ones, had a significant survival disadvantage persisting at each sex and age subgroup and all stages of cancer compared with the married subjects. The phenomena suggested that the benefits of marriage on all outcomes evaluated in subgroup analyses had additional underlying etiologies, except for the hypotheses related to the above mentioned risk factors. A widely accepted explanation of why married people had lower mortality from cancer is with regard to a better socioeconomic status, which has been postulated to buffer the effects of stressful events [27](#cam4778-bib-0027){ref-type="ref"}, [28](#cam4778-bib-0028){ref-type="ref"}. Chronic stress may elicit prolonged secretion of cortisol [29](#cam4778-bib-0029){ref-type="ref"}, which triggers a counter‐regulatory response of white blood cells by downregulating their cortisol receptors. This downregulation, in turn, reduces the cell capacity to respond to anti‐inflammatory signals and allows cytokine‐mediated inflammatory processes to flourish [30](#cam4778-bib-0030){ref-type="ref"}, which have been validated as poor prognostic factors in cancers [31](#cam4778-bib-0031){ref-type="ref"}, [32](#cam4778-bib-0032){ref-type="ref"}. Married persons may also enjoy greater financial resources than those who are widowed or divorced due to gains from economies of scale. Evidence for this correlation between marriage and socioeconomic status is widespread throughout the world, and better socioeconomic status has the potential to allow for decreased non‐medically related stress, due to increasing access to healthcare, better food, and better housing [33](#cam4778-bib-0033){ref-type="ref"}. In contrast, the diagnosis of cancer in widowed persons, who have no partner to share emotional burden and provide appropriate social support, may result in more distress, depression, and anxiety than their married counterparts. Of note, none of previous studies were designed to address the mechanisms whereby poor socioeconomic status contributed to increased mortality; thus, the concept is not universally accepted until further investigations on this subject have been warranted.

Although many studies have revealed survival differences between categories of married and unmarried patients, they may be not true across the board. In present study, multivariate analyses showed that the survival advantage of marriage was lost to never married individuals; additionally, when non‐married patients were further classified into never married, divorced, and widowed groups, never married or divorced group did not carry the worse survival outcomes for cancer compared to the widowed in subgroup analyses. Being divorced predicted significantly higher risk for mortality in each sex, elderly patients, and stage IV cancers, while the difference of survival between the never married and married group was even not apparent in any stratification. This suggested that marriage itself may increase the likelihood of early diagnosis and treatment of cancer at a young age, or correlate with decreased rates of depression, distress, and anxiety, but it does not independently affect survival in DTC patients.

Albeit this study is both enlightening and relevant to clinical practice; it had several limitations. First, the SEER database only provides the marital status at diagnosis. A few studies have found that the excess all‐cause mortality of the unmarried has increased over time, and the same pattern has been shown for some specific causes of death [34](#cam4778-bib-0034){ref-type="ref"}. In the same way, whether the marital status changed after diagnosis is unknown, and this change may also affect the survival. Second, the lack of detailed patient information, such as patient financial status, the existence of preexisting conditions, and mental health, prevents a subset of potential confounders from being accounted for in our analysis as well as disallows us to propose specific mechanisms on why marriage offers increased survival in SEER database. Finally, considering the favorable prognosis of DTC patients, the absence of information on recurrence or distant metastasis after initial therapy in the SEER database limits the evaluation of the effect of marital status on recurrence‐free survival. While this study remains the first of its kind analyzing the effects of marital status on survival in DTC in the American population, each of these limitations must be addressed in future studies to fully decipher what effect marriage truly has on DTC prognosis.

In summary, the data are consistent with the hypotheses mentioned above that marriage somehow protects the patients. An alternative explanation is that although marriage by itself is not protective (i.e., no decreased risk for CSS than never married), once you get married, getting a divorced or become widowed becomes hardship, both physical and psychological. This may be a better explanation. From a societal‐public health standpoint, the first hypothesis has implication of encouraging marriage as a public health measure, whereas, the second hypothesis would discourage divorce and encourage remarriage after widowhood.

Despite these potential limitations, our study had separated non‐married patients based on being never married, divorced, and widowed, and we analyzed each sex, age, and cancer stage individually with a series of traditional risk factors taken into account. Our results confirmed that the unmarried status has an independent impact on cancer‐specific mortality with a varied risk compared with married status. Moreover, we indicated that the unmarried patients groups were heterogeneous, and the widowed patients were always at the highest risk of death of cancer compared with those in other groups. Elderly age, advanced cancer stage, and psychosocial factors may be the reasons for poor survival outcomes in widowed or divorced patients. Physicians caring for these should be aware of their poorer outcomes. Social support systems should provide adequate care and interventions for these patients to help reduce the significant survival differences between married and unmarried patients with DTC, especially for widowed patients.
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